Our understanding of the role of myeloid-derived suppressor cells (MDSCs) in cancer is becoming increasingly complex. In addition to their eponymous role in suppressing immune responses, they directly support tumor growth, differentiation, and metastasis in a number of ways that are only now beginning to be appreciated. It is because of this increasingly complex role that these cells may become an important factor in the treatment of human cancer. In this Review, we discuss the most pertinent and controversial issues of MDSC biology and their role in promoting cancer progression and highlight how these cells may be used in the clinic, both as prognostic factors and as therapeutic targets.
Douglas Marvel, Dmitry I. Gabrilovich
Title and authors | Publication | Year |
---|---|---|
Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells
Themis Alissafi, Aikaterini Hatzioannou, Konstantinos Mintzas, Roza Maria Barouni, Aggelos Banos, Sundary Sormendi, Alexandros Polyzos, Maria Xilouri, Ben Wielockx, Helen Gogas, Panayotis Verginis |
Journal of Clinical Investigation | 2018 |
ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer
Sushil Kumar, David Wilkes, Nina Samuel, M. Andres Blanco, Anupma Nayak, Kevin Alicea-Torres, Christian Gluck, Satrajit Sinha, Dmitry I. Gabrilovich, Rumela Chakrabarti |
Journal of Clinical Investigation | 2018 |
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
Priyamvada Jayaprakash, Midan Ai, Arthur Liu, Pratha Budhani, Todd Bartkowiak, Jie Sheng, Casey R Ager, Courtney Nicholas, Ashvin R Jaiswal, Yanqiu Sun, Krishna Shah, Sadhana Balasubramanyam, Nan Li, Guocan Wang, Jing Ning, M. Anna Zal, Tomasz Zal, Michael A. Curran |
Journal of Clinical Investigation | 2018 |
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma
Veronica Huber, Viviana Vallacchi, Viktor Fleming, Xiaoying Hu, Agata Cova, Matteo Dugo, Eriomina Shahaj, Roberta Sulsenti, Elisabetta Vergani, Paola Filipazzi, Angela De Laurentiis, Luca Lalli, Lorenza Di Guardo, Roberto Patuzzo, Barbara Vergani, Elena Casiraghi, Mara Cossa, Ambra V Gualeni, Valentina Bollati, Flavio Arienti, Filippo de Braud, Luigi Mariani, Antonello Villa, Peter Altevogt, Viktor Umansky, Monica Rodolfo, Licia Rivoltini |
Journal of Clinical Investigation | 2018 |
Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis
G Qin, J Lian, L Huang, Q Zhao, S Liu, Z Zhang, X Chen, D Yue, L Li, F Li, L Wang, V Umansky, B Zhang, S Yang, Y Zhang |
OncoImmunology | 2018 |
Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation
M Taki, K Abiko, T Baba, J Hamanishi, K Yamaguchi, R Murakami, K Yamanoi, N Horikawa, Y Hosoe, E Nakamura, A Sugiyama, M Mandai, I Konishi, N Matsumura |
Nature Communications | 2018 |
Plasticity of myeloid-derived suppressor cells in cancer
E Tcyganov, J Mastio, E Chen, DI Gabrilovich |
Current Opinion in Immunology | 2018 |
The inflammatory function of human IgA
IS Hansen, DL Baeten, J den Dunnen |
Cellular and Molecular Life Sciences | 2018 |
Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses
F Hossain, S Majumder, DA Ucar, PC Rodriguez, TE Golde, LM Minter, BA Osborne, L Miele |
Frontiers in immunology | 2018 |
Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma
KW Moyes, A Davis, V Hoglund, K Haberthur, NA Lieberman, SA Kreuser, GH Deutsch, S Franco, D Locke, MO Carleton, DG Gilbertson, R Simmons, C Winter, J Silber, LF Gonzalez-Cuyar, RG Ellenbogen, CA Crane |
OncoImmunology | 2018 |
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
V Fleming, X Hu, R Weber, V Nagibin, C Groth, P Altevogt, J Utikal, V Umansky |
Frontiers in immunology | 2018 |
Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer
L Barrera, E Montes-Servín, JM Hernandez-Martinez, M Orozco-Morales, E Montes-Servín, D Michel-Tello, RA Morales-Flores, D Flores-Estrada, O Arrieta |
Cancer Immunology, Immunotherapy | 2018 |
Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
A Albini, A Bruno, DM Noonan, L Mortara |
Frontiers in immunology | 2018 |
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors
S Gupta, A Jain, SN Syed, RG Snodgrass, B Pflüger-Müller, MS Leisegang, A Weigert, RP Brandes, I Ebersberger, B Brüne, D Namgaladze |
OncoImmunology | 2018 |
Monocytes Differentiate to Immune Suppressive Precursors of Metastasis-Associated Macrophages in Mouse Models of Metastatic Breast Cancer
T Kitamura, D Doughty-Shenton, L Cassetta, S Fragkogianni, D Brownlie, Y Kato, N Carragher, JW Pollard |
Frontiers in immunology | 2018 |
A 2A Adenosine Receptor Gene Deletion or Synthetic A 2A Antagonist Liberate Tumor-Reactive CD8 + T Cells from Tumor-Induced Immunosuppression
J Kjaergaard, S Hatfield, G Jones, A Ohta, M Sitkovsky |
Journal of immunology (Baltimore, Md. : 1950) | 2018 |
Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation
YM He, X Li, M Perego, Y Nefedova, AV Kossenkov, EA Jensen, V Kagan, YF Liu, SY Fu, QJ Ye, YH Zhou, L Wei, DI Gabrilovich, J Zhou |
Nature Medicine | 2018 |
Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
MZ Afzal, RR Mercado, K Shirai |
Journal for ImmunoTherapy of Cancer | 2018 |
S100A4 Protects Myeloid-Derived Suppressor Cells from Intrinsic Apoptosis via TLR4–ERK1/2 Signaling
Q Li, C Dai, R Xue, P Wang, L Chen, Y Han, U Erben, Z Qin |
Frontiers in immunology | 2018 |
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
MU Mushtaq, A Papadas, A Pagenkopf, E Flietner, Z Morrow, SG Chaudhary, F Asimakopoulos |
Journal for ImmunoTherapy of Cancer | 2018 |
Expansion of Granulocytic, Myeloid-Derived Suppressor Cells in Response to Ethanol-Induced Acute Liver Damage
S Li, N Wang, HY Tan, M Hong, MF Yuen, H Li, Y Feng |
Frontiers in immunology | 2018 |
Polymorphonuclear Leukocytes in Pulmonary Hypertension and Fibrosis: Not Always What They Appear to Be
N Durmus, G Grunig |
American journal of respiratory cell and molecular biology | 2018 |
NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma
CH Yen, HH Hsiao |
International journal of molecular sciences | 2018 |
Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
E Zhang, J Gu, H Xu |
Molecular Cancer | 2018 |
STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity
YL Su, S Banerjee, S White, M Kortylewski |
International journal of molecular sciences | 2018 |
Dietary Protein Restriction Reprograms Tumor-Associated Macrophages and Enhances Immunotherapy
A Orillion, NP Damayanti, L Shen, R Adelaiye-Ogala, H Affronti, M Elbanna, S Chintala, M Ciesielski, L Fontana, C Kao, BD Elzey, TL Ratliff, DE Nelson, D Smiraglia, SI Abrams, R Pili |
Clinical cancer research | 2018 |
Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer
F Li, Y Zhao, L Wei, S Li, J Liu |
Cancer biology & therapy | 2018 |
Neutrophil elastase in the tumor microenvironment
I Lerman, SR Hammes |
Steroids | 2018 |
MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target
T Zhang, J Zhou, GC Man, KT Leung, B Liang, B Xiao, X Ma, S Huang, H Huang, VL Hegde, Y Zhong, Y Li, GW Kong, AK Yiu, J Kwong, PC Ng, PS Nagarkatti, M Nagarkatti, CC Wang |
European Journal of Immunology | 2018 |
Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin
YS Lee, E Davila, T Zhang, HP Milmoe, SN Vogel, JS Bromberg, JR Scalea |
Innate immunity | 2018 |
Metastatic niche functions and therapeutic opportunities
T Celià-Terrassa, Y Kang |
Nature Cell Biology | 2018 |
Aging Mouse Models Reveal Complex Tumor-Microenvironment Interactions in Cancer Progression
H Mori, RD Cardiff, AD Borowsky |
Frontiers in Cell and Developmental Biology | 2018 |
The level of myeloid-derived suppressor cells positively correlates with regulatory T cells in the blood of children with transient hypogammaglobulinaemia of infancy
I Siemińska, M Rutkowska-Zapała, K Bukowska-Strakova, A Gruca, A Szaflarska, K Kobylarz, M Siedlar, J Baran |
CENT EUR J IMMUNOL | 2018 |
Perspectives of Immune Suppression in the Tumor Microenvironment Promoting Oral Malignancy
N Kondoh, M Mizuno-Kamiya, E Takayama, H Kawati, N Umemura, Y Yamazaki, K Mitsudo, I Tohnai |
The open dentistry journal | 2018 |
The neutrophil: one cell on many missions or many cells with different agendas?
G Christoffersson, M Phillipson |
Cell and Tissue Research | 2018 |
Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression
CM Rice, LC Davies, JJ Subleski, N Maio, M Gonzalez-Cotto, C Andrews, NL Patel, EM Palmieri, JM Weiss, JM Lee, CM Annunziata, TA Rouault, SK Durum, DW McVicar |
Nature Communications | 2018 |
Concomitant type I IFN and M-CSF signaling reprograms monocyte differentiation and drives pro-tumoral arginase production
Y Tong, L Zhou, L Yang, P Guo, Y Cao, FX Qin, J Liu |
EBioMedicine | 2018 |
Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
BJ Christmas, CI Rafie, AC Hopkins, BA Scott, HS Ma, KA Cruz, S Woolman, TD Armstrong, RM Connolly, NA Azad, EM Jaffee, ET Torres |
Cancer immunology research | 2018 |
Caspase-1 from Human Myeloid-Derived Suppressor Cells Can Promote T Cell–Independent Tumor Proliferation
Q Zeng, J Fu, M Korrer, M Gorbounov, PJ Murray, D Pardoll, DL Masica, YJ Kim |
Cancer immunology research | 2018 |
Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance
MA Meyer, JM Baer, BL Knolhoff, TM Nywening, RZ Panni, X Su, KN Weilbaecher, WG Hawkins, C Ma, RC Fields, DC Linehan, GA Challen, R Faccio, RL Aft, DG DeNardo |
Nature Communications | 2018 |
Myeloid-derived suppressor cells coming of age
F Veglia, M Perego, D Gabrilovich |
Nature Immunology | 2018 |
Adaptive NK cells resist regulatory T cell suppression driven by IL-37
D Sarhan, KL Hippen, A Lemire, S Hying, X Luo, T Lenvik, J Curtsinger, Z Davis, B Zhang, S Cooley, F Cichocki, BR Blazar, JS Miller |
Cancer immunology research | 2018 |
Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
JW DiGiacomo, DM Gilkes |
Targeted Oncology | 2018 |
Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma
J Retseck, A Nasr, Y Lin, H Lin, P Mendiratta, LH Butterfield, AA Tarhini |
Journal of Translational Medicine | 2018 |
Immunosuppressive monocytes (CD14+/HLA-DRlow/−) increase in childhood precursor B-cell acute lymphoblastic leukemia after induction chemotherapy
DS Lima, RP Lemes, DM Matos |
Medical Oncology | 2018 |
A preclinical model to investigate the role of surgically-induced inflammation in tumor responses to intraoperative photodynamic therapy: PRECLINICAL MODEL OF SURGICAL INFLAMMATION
RW Davis, E Papasavvas, A Klampatsa, M Putt, LJ Montaner, MJ Culligan, S McNulty, JS Friedberg, CB Simone, S Singhal, SM Albelda, KA Cengel, TM Busch |
Lasers in Surgery and Medicine | 2018 |
The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models
H Läubli, P Müller, L DAmico, M Buchi, AS Kashyap, A Zippelius |
Cancer Immunology, Immunotherapy | 2018 |
Aberrant erythropoiesis fuels tumor growth
K Nakamura, MJ Smyth |
Cell Research | 2018 |
Microarray analysis of long non-coding RNA expression profiles in monocytic myeloid-derived suppressor cells in Echinococcus granulosus-infected mice
A Yu, Y Wang, J Yin, J Zhang, S Cao, J Cao, Y Shen |
Parasites & vectors | 2018 |
Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model
Y Qi, K Xing, L Zhang, F Zhao, M Yao, A Hu, X Wu |
Journal of Cancer Research and Clinical Oncology | 2018 |
Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer
R Yang, T Cai, X Wu, Y Liu, J He, X Zhang, G Ma, J Li |
Immunology | 2018 |
Assessing the Role of DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio in Rheumatoid Arthritis
S Ambatipudi, GC Sharp, SL Clarke, D Plant, JH Tobias, DM Evans, A Barton, CL Relton |
Journal of Immunology Research | 2018 |
The Shifting Paradigm of Prognostic Factors of Colorectal Liver Metastases: From Tumor-Centered to Host Immune-Centered Factors
M Donadon, A Lleo, LD Tommaso, C Soldani, B Franceschini, M Roncalli, G Torzilli |
Frontiers in Oncology | 2018 |
New opportunities for nanoparticles in cancer immunotherapy
W Park, YJ Heo, DK Han |
Biomaterials Research | 2018 |
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
HG Wiktorin, MS Nilsson, R Kiffin, FE Sander, B Lenox, A Rydström, K Hellstrand, A Martner |
Cancer Immunology, Immunotherapy | 2018 |
Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy
A Tuccitto, E Shahaj, E Vergani, S Ferro, V Huber, M Rodolfo, C Castelli, L Rivoltini, V Vallacchi |
Virchows Archiv | 2018 |
AAV-Vectored Fms-Related Tyrosine Kinase 3 Ligand Inhibits CD34+ Progenitor Cell Engraftment in Humanized Mice
L Ling, X Tang, X Huang, J Li, H Wang, Z Chen |
Journal of Neuroimmune Pharmacology | 2018 |
Intratumoral delivery of antigen with complement C3-bound liposomes reduces tumor growth in mice
A Francian, S Namen, M Stanley, K Mann, H Martinson, M Kullberg |
Nanomedicine : nanotechnology, biology, and medicine | 2018 |
Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes
L Li, B Cao, X Liang, S Lu, H Luo, Z Wang, S Wang, J Jiang, J Lang, G Zhu |
Oncogene | 2018 |
The failure of radical treatments to cure cancer: can less deliver more?
AG Dalgleish, PL Stern |
2018 | |
Computational Immune Monitoring Reveals Abnormal Double-Negative T Cells Present across Human Tumor Types
AR Greenplate, DD McClanahan, BK Oberholtzer, DB Doxie, CE Roe, KE Diggins, N Leelatian, ML Rasmussen, MC Kelley, V Gama, PJ Siska, JC Rathmell, PB Ferrell, DB Johnson, JM Irish |
Cancer immunology research | 2018 |
Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer
H Kuroda, S Mabuchi, E Yokoi, N Komura, K Kozasa, Y Matsumoto, M Kawano, R Takahashi, T Sasano, K Shimura, M Kodama, K Hashimoto, K Sawada, E Morii, T Kimura |
Oncotarget | 2018 |
Establishment of malignantly transformed dendritic cell line SU3-ihDCTC induced by Glioma stem cells and study on its sensitivity to resveratrol
X Fei, A Wang, D Wang, X Meng, J Ma, L Hong, R Qin, A Wang, J Dong, Q Huang, Z Wang |
BMC Immunology | 2018 |
Autocrine TGFβ Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment
A Gonzalez-Junca, KE Driscoll, I Pellicciotta, S Du, CH Lo, R Roy, R Parry, I Tenvooren, DM Marquez, MH Spitzer, MH Barcellos-Hoff |
Cancer immunology research | 2018 |
Combining immunotherapy with radiation therapy in thoracic oncology
SN Badiyan, MC Roach, MD Chuong, SR Rice, NE Onyeuku, J Remick, S Chilukuri, E Glass, P Mohindra, CB Simone |
Journal of Thoracic Disease | 2018 |
Interferon-γ and Colorectal Cancer: an up-to date
C Kosmidis, K Sapalidis, T Koletsa, M Kosmidou, C Efthimiadis, G Anthimidis, N Varsamis, N Michalopoulos, C Koulouris, S Atmatzidis, L Liavas, TM Strati, G Koimtzis, A Tsakalidis, S Mantalovas, K Zarampouka, M Florou, DE Giannakidis, E Georgakoudi, S Baka, P Zarogoulidis, YG Man, I Kesisoglou |
Journal of Cancer | 2018 |
Salidroside prevents skin carcinogenesis induced by DMBA/TPA in a mouse model through suppression of inflammation and promotion of apoptosis.
Kong YH, Xu SP |
Oncology reports | 2018 |
Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma.
Ilié M, Beaulande M, Ben Hadj S, Chamorey E, Schiappa R, Long-Mira E, Lassalle S, Butori C, Cohen C, Leroy S, Guérin O, Mouroux J, Marquette CH, Pomerol JF, Erb G, Hofman V, Hofman P |
Cancers | 2018 |
Resveratrol ameliorates Lewis lung carcinoma‐bearing mice development, decreases granulocytic myeloid‐derived suppressor cell accumulation and impairs its suppressive ability
Zhao Y, Shao Q, Zhu H, Xu H, Long W, Yu B, Zhou L, Xu H, Wu Y, Su Z |
Cancer Science | 2018 |
Reduction of myeloid-derived suppressor cells reinforces the anti-solid tumor effect of recipient leukocyte infusion in murine neuroblastoma-bearing allogeneic bone marrow chimeras
Dierckx de Casterlé I, Fevery S, Rutgeerts O, Poosti F, Struyf S, Lenaerts C, Waer M, Billiau AD, Sprangers B |
Cancer Immunology, Immunotherapy | 2018 |
Interactions among myeloid regulatory cells in cancer
Umansky V, Adema GJ, Baran J, Brandau S, Van Ginderachter JA, Hu X, Jablonska J, Mojsilovic S, Papadaki HA, Pico de Coaña Y, Santegoets KC, Santibanez JF, Serre K, Si Y, Sieminska I, Velegraki M, Fridlender ZG |
Cancer Immunology, Immunotherapy | 2018 |